Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Differential expression of VEGF ligands and receptors in prostate cancer.

Woollard DJ, Opeskin K, Coso S, Wu D, Baldwin ME, Williams ED.

Prostate. 2013 May;73(6):563-72. doi: 10.1002/pros.22596. Epub 2012 Oct 4.

PMID:
23038639
2.

Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.

Berzsenyi MD, Woollard DJ, McLean CA, Preiss S, Perreau VM, Beard MR, Scott Bowden D, Cowie BC, Li S, Mijch AM, Roberts SK.

J Hepatol. 2011 Sep;55(3):536-544. doi: 10.1016/j.jhep.2010.12.021. Epub 2011 Jan 23.

PMID:
21266183
3.

Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection.

Berzsenyi MD, Roberts SK, Preiss S, Woollard DJ, Beard MR, Skinner NA, Bowden DS, Visvanathan K.

J Viral Hepat. 2011 Dec;18(12):852-60. doi: 10.1111/j.1365-2893.2010.01390.x. Epub 2010 Nov 3.

PMID:
21050341
4.

Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets.

Woollard DJ, Haqshenas G, Dong X, Pratt BF, Kent SJ, Gowans EJ.

J Virol. 2008 Mar;82(6):3054-60. Epub 2007 Dec 19.

5.

Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.

Li S, Jones KL, Woollard DJ, Dromey J, Paukovics G, Plebanski M, Gowans EJ.

Immunol Cell Biol. 2007 Apr-May;85(3):197-204. Epub 2007 Jan 2.

PMID:
17199111
6.

Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.

Woollard DJ, Grakoui A, Shoukry NH, Murthy KK, Campbell KJ, Walker CM.

Hepatology. 2003 Nov;38(5):1297-306. Erratum in: Hepatology. 2003 Dec;38(6):1602.

PMID:
14578870
7.

HCV persistence and immune evasion in the absence of memory T cell help.

Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM, Walker CM.

Science. 2003 Oct 24;302(5645):659-62.

8.

Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens.

Woollard DJ, Heath DD, Lightowlers MW.

Parasitology. 2000 Aug;121 ( Pt 2):145-53.

PMID:
11085234
9.

Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes.

Woollard DJ, Gauci CG, Heath DD, Lightowlers MW.

Vaccine. 2000 Oct 15;19(4-5):498-507.

PMID:
11027814
10.

Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus.

Woollard DJ, Gauci CG, Lightowlers MW.

Vaccine. 1999 Dec 10;18(9-10):785-94.

PMID:
10580190
11.

Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.

Lightowlers MW, Jensen O, Fernandez E, Iriarte JA, Woollard DJ, Gauci CG, Jenkins DJ, Heath DD.

Int J Parasitol. 1999 Apr;29(4):531-4.

PMID:
10428628
12.

Epitope specificities and antibody responses to the EG95 hydatid vaccine.

Woollard DJ, Gauci CG, Heath DD, Lightowlers MW.

Parasite Immunol. 1998 Nov;20(11):535-40.

13.

Characterization of 5-HT receptors mediating contraction and relaxation of the longitudinal muscle of guinea-pig distal colon in vitro.

Woollard DJ, Bornstein JC, Furness JB.

Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):455-62.

PMID:
8065459
14.

Characterization of 5-hydroxytryptamine receptors mediating mucosal secretion in guinea-pig ileum.

Johnson PJ, Bornstein JC, Furness JB, Woollard DJ, Orrman-Rossiter SL.

Br J Pharmacol. 1994 Apr;111(4):1240-4.

Supplemental Content

Loading ...
Support Center